Trevi Therapeutics TRVI
NASDAQ TRVI
$12.77 -0.06 (-0.47%)
At close: Oct 21, 2026 · 4:00 PM EDT

Trevi Therapeutics (TRVI) Interest Paid (2018 - 2020)

Updated

Analysis

Trevi Therapeutics (TRVI) Interest Paid (2018 - 2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Paid (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 339.00 Mn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 1.07 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 1.25 Bn
10 Trevi Therapeutics 2.00 Bn 1.13 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 150,000.00
Jun 30, 2018 56,000.00
Mar 31, 2018 96,000.00
API Access

Trevi Therapeutics Interest Paid API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-paid&ticker=TRVI&period=max&api_key=YOUR_API_KEY